Organon CEO exits after internal probe over ‘channel stuffing’ to boost salesnews2025-10-27T18:29:50+00:00October 27th, 2025|Endpoints News|
Regeneron reaches patent deal with Celltrion over Eylea biosimilarnews2025-10-21T18:16:52+00:00October 21st, 2025|Endpoints News|
Three drugs push CBO to raise orphan cost estimate to $8.8B over 10 yearsnews2025-10-20T18:16:04+00:00October 20th, 2025|Endpoints News|
FDA tells Supreme Court to pass on Vanda’s fast-track status fightnews2025-10-16T16:47:56+00:00October 16th, 2025|Endpoints News|
Supreme Court passes on fight over FDA stem cell regulationnews2025-10-14T16:07:37+00:00October 14th, 2025|Endpoints News|
California enacts state law building on PBM reformsnews2025-10-13T19:24:46+00:00October 13th, 2025|Endpoints News|
Third Circuit appeals court tosses Novo Nordisk’s IRA case news2025-10-07T19:11:42+00:00October 7th, 2025|Endpoints News|
HHS reorganization suit must proceed despite government shutdown, court rulesnews2025-10-03T19:37:01+00:00October 3rd, 2025|Endpoints News|
Legal pressure builds around FDA’s new DTC pharma ad crackdownnews2025-10-03T18:51:43+00:00October 3rd, 2025|Endpoints News|
Vanda ends lawsuits against FDA as part of wide-ranging agreement with agencynews2025-10-02T18:37:35+00:00October 2nd, 2025|Endpoints News|
